This study was designed to evaluate results, especially mortality and morbidity, of surgical resection with cm~ative intent for patients with a local recurrence of rectal cancer, in combination with radiotherapy. METHODS: Consecutive medical records of 163 patients with local recurrence of rectal carcinoma after previous "curative" therapy for primary rectal cancer were reviewed. Although 35 patients had an exploratory laparotomy, only 27 had local recurrence amendable to resection (6 irresectable locoregional recurrences and 2 distant metastases found at laparotomy). Twenty-one patients received radiotherapy. There was no perioperative mortality. Median follow-up time was 42 (range, 22-92) months. RESULTS: Local rerecurrence occurred in 16 (59 percent) patients. Ten patients are alive, of whom nine have good local control. Estimated five-year survival (Kaplan-Meier) is 20 percent. Survival was significantly better in patients without a second recurrence, but radicality of the resection was not influential. Good local control could be obtained in 12 (44 percent) patients, and 1 patient is living with symptoms. CONCLUSIONS: In selected patients with local recurrence of rectal carcinoma, reoperation with irradiation may result in good palliation and possibly cure. [
established scheme to consult. Depending on treatment of primary tumor, different modalities of treatment, such as surgery, radiotherapy, hyperthermia, chemotherapy, or combinations, have been used, but the optimal treatment schedule remains to be established. Of these therapeutic options, surgery (if feasible), in combination with radiotherapy, can provide the best results with regard to survival and local control. Extent of surgery is mainly determined not only by extent of LR and type of primary surgery but also whether adjuvant radiotherapy was previously given. For a recurrence at the anastomotic site, reresection (mostly APR) can be curative. 9-1l To patients with recurrence involving pelvic structures (viscera, pelvic wall), pelvic exenterations or even more extended operations with sacral resection may be offered, whereas in the event of LR that is incurable because of distant metastasis, surgical therapy can offer a reasonable palliation in controlling symptoms such as perineal infection or bleeding. [12] [13] [14] [15] [16] [17] In this retrospective study, we evaluated our results, especially mortality and morbidity, of surgical resection with curative intent for selected patients with LR of rectal carcinoma, in combination with radiotherapy. At the same time an analysis was performed to find potential factors influencing survival and local control after surgery for LR.
PATIENTS AND METHODS
We have defined LR as relapsed tumor growth within the pelvic cavity, after a curative operation for primary rectal cancer. Between January 1984 and March 1993, 163 patients came to our department with (histologically proven) LR. Previous operation and initial follow-up in most patients had been done elsewhere. To determine whether surgical resection could be performed, all patients were evaluated by a general blood investigation, carcinoembryonic antigen (CEA) determination, chest x-ray, ultrasonography, and/or computed tomographic scan of the upper abdomen (focusing 324 on the liver) to exclude detectable distant metastases. LR was evaluated by a computed tomographic scan of the pelvis and, if possible, a rectal and/or vaginal investigation under general anesthesia. Patients with distant metastases and/or demonstrable extensive involvement of the (lateral) pelvic wall, presenting with venous obstruction or bilateral sciatic pain caused by LR, were not considered for an operation with curative intent. In this manner, 35 patients were left for analysis and underwent laparotomy with curative intent because of LR of rectal cancer. There were 20 males and 15 females, with an age ranging from 45 to 88 (median, 61) years. In these 35 patients, time between primary operation and detection of LR ranged from 3 to 60 (median, 11) months. In 19 (54 percent) patients, LR developed in the first year of follow-up, and 27 (77 percent) patients developed LR within the first two years of follow-up. In 26 patients symptoms led to diagnosis of LR, whereas in 9 patients, LR was asymptomatic. Symptoms at presentation are outlined in Table 1 . Primary operation in 30 patients was a LAR and in 5 patients an APR. Six patients had been irradiated as adjuvant therapy: two patients preoperatively with a dose of 30 respectively 34 Gy and four patients postoperatively with a median dose of 50 (range, 40-55) Gy. Primary tumor had a diameter ranging from 2 to 8 (median, 4) cm. Histopathologic study of specimen indicated that 5 tumors were well, 27 were moderately, and 3 were poorly differentiated adenocarcinoma. Initial TNM stage was T4,N0,M0 in 1, T3,N0,M0 in 17, T2,N1,M0 in 2, T3,N1,M0 in 9, and T3,N2,M0 in 6 cases. Number of lymph node metastases ranged from one to six (median, 3) nodes. In five primary specimens, angioinvasive growth was seen.
Type and date of operation for recurrence, blood loss, operation time, dose and time of radiotherapy, radicality WIGGERS ETAL Dis Colon Rectum, March 1996 (macroscopically and microscopically) of resection, preoperative and postoperative complications, and CEA levels were reviewed. Follow-up information included date of locoregional rerecurrence, site of rerecurrence (locoregional and/or distant metastases), whether local control (at date of latest follow-up) could be acquired, date of most recent follow-up, or date of death. Kaplan-Meier method was used to compute survival and disease-free survival probabilities and corresponding curves, whereas survival functions for subgroups were compared using the log-rank method. To identify patients who would benefit from a reresection and to test potential factors influencing survival after a reresection of LR, these variables were analyzed using the Cox multivariate proportional hazard model.
RESULTS
At the time of surgery, in six patients the LR turned out to be unresectable, whereas two had multiple, small distant metastases not detected by preoperative imaging, hence allowing only fecal diversion in eight (23 percent) patients. In 27 (77 percent) patients, LR could be resected. Four patients had synchronous radical resectable metastases; in one patient a small perineal metastasis was resected and in three patients a wedge resection of a solitary liver metastasis, detected by peroperative ultrasonography of the liver, was peffon:aed in the same session. Site of LR is outlined in Table 2 . In 17 patients, LR was fixed to the os sacrum. For this, in six patients, resection was extended dorsally with a partial resection of the os sacrum (below level S-3), and in four patients the resection was extended ventrally (pelvic exenteration). Essentially, in these resections, the pelvic floor was left unimpaired with the exception of two patients with LR invading the perineum. After resection, the penis was filled with a pedicled omentoplasty in 25 patients. 18 Operation time ranged from 50 to 380 (median, 240) minutes, and blood loss ranged from 500 to 9,000 (median, 2,850) ml. Radiotherapy, usually in fractions, was delivered preoperatively to 4 patients with a median dose of 50 (range, 30-60) Gy, postoperatively to 13 patients with a median dose of 55 (range, 30-64) Gy (includes four cases with 15-Gy iridium brachytherapy), whereas 4 patients received "sandwich" radiotherapy with a total dose of 64.5 Gy. Usual dose was 1.8 to 2 Gy, five fractions a week. In no resection was macroscopic residue mass left behind, but in 13 (48 percent) patients the resection was microscopically irradical. Postoperative hospitalization time ranged from 2 to 34 (median, 16.5) days. In this period, 8 (30 percent) patients had a complication; three patients developed a urinary u'act infection, whereas three patients developed a wound infection (one abdominal and two perineal), one patient had a hemorrhage, and in one patient a transurethral resection of the prostate was performed. There was no perioperative mortality. Median follow-up time counted from time of operation for LR was 42 (range, 22-92) months.
Rerecurrence
After a median disease-free interval of eight (range, 1-26) months, 16 (59 percent) patients developed a second local recurrence, of whom 6 had synchronous distant metastases. In five other patients, only distant metastases occurred (Table 3 ). Symptoms are outlined in Table 4 . Palliative radiotherapy was performed in two patients, both died with symptoms within one year after operation. In three patients, a relaparotomy was performed. In one patient, a debulking of a parastomal rerecurrence was performed, whereas in one patient a subsequent radical resection of the bladder was followed by a Bricker deviation. One other patient had a reoperation because of bowel obstruction in combination with hydronephrosis because of rerecurrence, allowing only fecal diversion.
Survival
In our series, there are 10 (37 percent) survivors, and there have been 17 (63 percent) deaths. Nine 
Multivariate Analysis
A study of the following factors possibly related to mortality and survival-time was undertaken; characteristics of the primary tumor, initial disease-free interval, whether LR was symptomatic, localization of recurrence, characteristics of resection (operation time, blood loss, and macroscopic and microscopic radicality), adjuvant radiotherapy, CEA concentrations, development of rerecurrence, and whether local control was obtained.
Of these factors, only three were statistically related with five-year survival. There was a significant difference in mortality and survival time between patients with a reresection and patients with only a fecal diversion (chi-squared = 6.5; df = 1, P = 0.01) ( Fig. 1 ). Years after re-resection. This was also the case between the group of patients who developed a second local recurrence and/or distant metastases compared with the group who did not (chi-squared = 5.7; df = 1, P < 0.02). Also the group in which local control was obtained had a better survival than the group that did not (chi-squared = 5; df = 1, P < 0.02).
DISCUSSION
Without any treatment, LR generally heralds a yew poor prognosis, with median survival periods ranging from 3.5 to 13 months and five-year survival from 0 to 5 percent. < 19-21 Because of this poor natural history together with the major disability and impaired performance status that occurs in this situation, eventually most patients will receive some kind of therapy. True enough, radiotherapy and chemotherapy decrease LR rate if given adjuvantly, 22-27 but once LR has developed, they show only short-term relief of symptoms and no curative potential with only few, if any, long-term survivors. 28' 29 Majority of patients with LR will require surgical intervention either to determine resectability or to treat complications like obstruction and perforation. As long ago as 1959, Bacon and Berkley 3~ reported a group of 93 patients with LR. Among the 38 patients with a reresection for cure, five-year survival was 37 percent, 3~ Second resection (in association with radiation) of LR probably offers the best chance for improved local control and palliation. Five-year survival figures after a resection range from 9 to 48 percent, < 9-17, 19, 31 which is comparable with our estimated five-year survival of 20 percent in 27 patients with a resection for cure.
In case LR can be resected, few reports deal with evaluation of factors potentially influencing survival after reresection. Reviewing literature, most authors agree that survival after reresection depends mainly on localization and extension of LR, presence of symptoms, and radicality of reresection. 4 ' 20, 21, 30, 31 The so-called anastomotic recurrence after a previous LAR, is mostly located centrally in the pelvic cavity and may be caused by an incompletely resected mesorectum during the primary operation. Nevertheless, one must bear in mind that the anastomotic recurrence in the narrower sense is rather seldom 31 and is usually a part of an extensive extraluminal recurrence, growing into the anastomotic area. Preoperative evaluation of this type of LR is sometimes difficult because of scar tissue formation. This kind of LR has the highest resectability and survival rate up to 50 percent. 11 ' 21, 31, 32 LR following an APR or low-low anterior resection is more often located peripherally in the pelvis, is frequently more extensive, and invades the pelvic viscera and lateral or posterior pelvic wall presenting with sciatic pains. Recurrence invading the urogenital organs may be resected successfully by pelvic exenteration,33, 34 whereas surgery for perineal recurrences can result in prolonged palliation and even survival. 16 ' 17 When LR is invading the sacrum, conventional surgical resection can rarely be feasible and, as in six of our patients, combined resection of the sacral bone below S-3 is needed to obtain radical margins. More extensive operations like abdominal sacral resection, s5 inferior pelvectomy, and the like have been described by others.14. 35-38 However, one must realize that these operations are extensive with consequent mortality, long duration of operation (average, 18.5 hours) in two-stage procedm'es, extensive blood toss, and late morbidity because of neurogenic bladders and neuropathic pains. Furthermore, it is doubtful if more local tumor control can be obtained in this way, because long-term survival is similar to our series in which less morbidity and no postoperative mortality occurred. Candidates for those operations should, therefore, be selected very carefully.
In most studies, influence of early detection of LR on resectability and prognosis after reresection is stated.~9, 31.39 In prospective study by Schiessel et al. 2~ who evaluated the effect of a rigorous follow-up after resection of primary colorectal cancer on survival after surgery of LR, 50 percent of patients with a reresection were asymptomatic at the time of diagnosis of LR. In contradiction to these findings, we could not confirm the influence on survival of asymptomatic cases.
Recent studies suggest that ff external or intraoperative radiotherapy is added to surgical reresection of LR this results in better survival and local control. However, risk of further local recurrence would still be approximately 50 percent. 4~ In our study, local control rate in those patients receiving a cumulative radiation dose of more than 55 Gy was significantly better, compared with patients receiving less. To improve local control, more radical resections (total mesorectal excision or extended lymph node dissections 4547) have been suggested, but if recmTence does occur it will be doubtful if these patients will ever be candidates for reoperation because there will be wide-spread disease in the pelvic cavity. In patients with LR not amenable to resection because of extensive invasion or fixation to an unresectable structure, isolated pelvic peffusion chemotherapy, 4<49 whether in combination with preoperative and/or intraoperative radiation, may shrink the LR and facilitate a resection.
LOCAL RECURRENCE OF RECTAL CANCER 12.
CONCLUSIONS
In selected patients, without obviously unresectable LR, reoperation with radiation should be advised. However, based on literature and own experience, we do not perform more extended surgew in patients with extensive involvement of lateral pelvic wall, with signs of venous obstruction or bilateral sciatic pain. Furthermore, we reserve palliative surgery only for those patients with conservative uncontrollable local recurrent infections caused by LR.
